Global Point of Care Diagnostics - POCD
Market Report
2024
Point of Care Diagnostics - POCD Market Report 2024 (Global Edition)
Point of Care diagnostics market was valued at USD 39.9 billion in 2022 and is projected to reach USD 59.4 billion by 2030, registering a CAGR of 5.1% for the forecast period 2023-2030.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of Point of Care Diagnostics - POCD Market Report 2024.
Global Point of Care Diagnostics - POCD Market Report 2024 Market Size Split by Product (Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease, Infections, Cardi...
The global Point of Care diagnostics market was valued at USD 39.9 billion in 2022 and is projected to reach USD 59.4 billion by 2030, registering a CAGR of 5.1% for the forecast period 2023-2030.
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global Point of Care Diagnostics - POCD Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 5.1% |
| Market Split by Product |
|
| Market Split by Offering |
|
| Market Split by Platform |
|
| Market Split by Sample Type |
|
| Market Split by End Use |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Point of Care Diagnostics - POCD industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Point of Care Diagnostics - POCD Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Point of Care Diagnostics - POCD Market Report Description
What is Point of Care Diagnostics?
Point-of-care testing (POCT) is a type of testing in which the analysis is carried out at the location where medical care is given to the patient or close by. Additional terms that have been used as alternatives include near patient testing (NPT), bedside testing, physician’s office testing (POL), off site testing, alternative site testing, etc. Point-of-care uses analytical tools to asses the results. The analytical devices include blood gas and critical care analysers. POCT is considered a preferable way rather than traditional testing. This testing has evolved around the globe due to its feasibility, performance and efficiency. It has a perceived ease of use as it is a near patient testing i.e., the patient can access the service any where without any prerequisite of laboratory. There are wide range of products that collect blood sample from the patients home and then taken to laboratory for the further testing.
What are the Factors Affecting the Growth of Point of Care Diagnostics Market?
- Rising rates of infectious diseases of Point of Care Diagnostics Market
The growing number of patients and the high disease rate has boosted the demand for point of care testing. The diseases like HIV, Covid-19 and other similar diseases have increased and thus the patients need faster response and adequate results without any complex procedures. For instance, the country with the highest reported use of POCT was France with 55 diseases, followed by Norway with 44 diseases. The demand for point of care testing is increasing at a moderate rate due to the direct relation with the chronic diseases.
- Decentralisation of the healthcare system
The evolution and enhancement of a decentralised healthcare system has increased. Many hospitals are shifting from traditional healthcare to an innovative healthcare system. The diagnostics services are now not only provided at a particular hospital but are now deviated from hospitals to physician’s workplace, pharmacies and also done at patients home for a better feasibility. This decentralisation has been prevailing in boosting the demand for point of care testing market.
- The Point of Care Diagnostics Market has been greatly affected byTechnological Advancements
The technological advancements like the introduction of Lab-on-chip are the key driver of the point-of-care testing market. These technologies enable the results of infectious diseases at a faster rate and provide the diagnosis easier. The two main technologies used to determine a variety of characteristics, including cardiac indicators and infectious microorganisms, are glucose biosensor strips and lateral flow strips utilising immobilised antibodies. For instance, according to hypotheses, POCT is rising by at least 10–12% annually, with certain regions experiencing annual increases of 30% due to the advancement in technology.
- Quality Assurance can control Point of Care Diagnostics Market
The main concern in point of care testing is the quality control and quality assurance. The quality assurance is carried on by a complex procedure which cannot be cost effective. There cannot be any responsible person for quality assurance in this case of testing. The potential lack of reliability can be attributed to a variety of factors, including personnel variation, testing procedures and applications and the methodology’s perceived ease of use.
- High Cost of Point of Care Diagnostics Market may hinder the growth of Point of Care Diagnostics Market
Point-of-care testing is more expensive as compared to the traditional diagnostics testing. The unit cost of point of care testing is more than the testing conducted in a traditional way or in a laboratory. For instance, POCT prices were from 1.1 to 4.6 times higher than central laboratory stat costs. In comparison to the central laboratory, the additional costs rise when POCT is utilised more frequently.
Current Trends of Point of Care Diagnostics Market
- Growing use of miniaturized testing
The world is coming closer through the use of cutting-edge technologies and innovations. The use of small and portable devices has increased due to high prevalence of feasibility and portability. The testing can be easily done anywhere without any location barrier. The increase of miniaturised technologies, the application of videoconferencing for remote monitoring, and the creation of less invasive and more continuous testing has been a trend for point-of-care testing. POCT enables detection of illnesses at an early stage by offering useful information at the time and location of care.
- Integrating connectivity and data
POCT devices are progressively being developed with the ability to connect and integrate with data management platforms, electronic health records, and healthcare information systems. Real-time test results transfer, smooth data processing, and improved patient care and monitoring are all made possible by this connectivity. According to the National Coordinator for Health Information Technology (ONC), in the United States, 78% of office-based doctors had HER technology certification as of 2021.
Impact of the COVID-19 Pandemic on the Point of Care Diagnostics Market
The pandemic had increased the demand for the Point of care diagnostics market. After the Covid-19 companies started to introduce new technologies and product for the rapid tests and quicker responses. A few months after the initial Covid-19 RT-PCR tests were implemented, POCT devices were introduced to the market to solve these problems. Covid-19 POC diagnostics, like the Abbott ID Now, which uses isothermal nucleic acid amplification, can offer results in 15 minutes or less despite having a lower capacity and enabling real-time diagnosis. For instance, the reverse transcription polymerase chain reaction (RT-PCR) test, which can accurately identify minute amounts of viral nucleic acid (SARS-CoV-2 RNA) in clinical specimens, is currently the gold standard for the diagnosis of acute SARS-CoV-2 infection. Thus, it had a positive impact on the point of care diagnostics market.
We have various report editions of Point of Care Diagnostics - POCD Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Competitive Analysis of the Point of Care Diagnostics Market
Many companies are involved in the designing of the new and innovative portable devices. For instance, in 2021, Siemens Healthcare launched product named Atellica VTLi Patient-Side Immunoassay Analyzer which will provide test results in 8 minutes using a patient's fingerstick blood sample.
Recent News- Point of Care Diagnostics Market
- March 2020- Abbott Introduces a Molecular Point-of-Care Test ID NOW to identify Coronavirus in just Five Minutes.
Abbott introduces a molecular point of care test to predict the results faster. The U.S Food and Drug Administration has issued a notification regarding the faster diagnosis by molecular point of care test for the detection of the corona virus. The new launch assesses the positive results in 5 minutes whereas assess the negative results in just 13 minutes. The ID NOW platform uses molecular technology, which is highly esteemed by doctors and the scientific community for its high level of accuracy. It is compact, light, portable, and uses molecular analysis. The most frequently used molecular point-of-care testing tool in the United States is ID NOW.
Top Companies Market Share in Point of Care Diagnostics - POCD Industry: (In no particular order of Rank)
- Danaher; Qiagen; Abbott; Siemens Healthcare AG; F. Hoffmann-La Roche Ltd.; bioMerieux SA; Nova Biomedical; Quidel Corp.; Sekisui Diagnostics; Trinity Biotech.
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
As per the published report North America held the largest revenue share in the year 2022!
North America accounted for the largest market share in the year 2022 due to the increase in the number of diseases and illness. North America has good infrastructure facilities, strong healthcare facilities and continuous expansion and innovation. There is use of cutting-edge point-of-care molecular diagnostics to identify diseases and infections, as well as an increase in research activity in this region. Growing numbers of people in the region are suffering from chronic diseases, and there are more procedures performed annually. North America has high healthcare expenditure particularly in United states. North America also has favourable regulatory environment with lesser complex procedures. This results in launch of new point of care testing products into the market and also assures the quality and standard of the product.
The current report Scope analyzes Point of Care Diagnostics - POCD Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Point of Care Diagnostics - POCD Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
Point of Care Diagnostics - POCD Market Analysis
Global Point of Care Diagnostics - POCD Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Point of Care Diagnostics - POCD Industry growth. Point of Care Diagnostics - POCD market has been segmented with the help of its Product, Offering Platform, and others. Point of Care Diagnostics - POCD market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
In 2022, The infectious disease segment accounted for the largest market share of Point of Care Diagnostics Market
The infectious diseases segment held the largest market share due to the growing chronic disease rate. This product can detect the virus or the disease in the minimal amount of time resulting in faster results. This provides the tests faster and easier. The other segments like Cardiac Markers, Cancer Marker, Lipid Testing has also observed a significant growth. Many companies are expanding their portfolio through this market. For instance, Cipla company launches a product named Cippoint, which offers different products which includes cardiac markers, infectious diseases, fertility, thyroid function, inflammation, metabolic markers, and coagulation markers.
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Infections
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
Point of Care Diagnostics - POCD Market Share (%) by Product in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Point of Care Diagnostics - POCD Industry. Request a Free Sample PDF!
In 2022, Point of Care Diagnostics Market software and services accounted for the highest share in the market
The growing use of AI and technologies, Software and services segment have held the largest market share. The adoption of MedTech and other integrated technologies have gained access to the growth in software services provided by the healthcare system.
Point of Care Diagnostics - POCD Market Share (%) by Offering in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Point of Care Diagnostics - POCD market report 2024 Edition by contacting our team.
Point of Care Diagnostics - POCD Platform Segment Analysis
- Lateral Flow Assays
- Molecular Diagnostics
- Other Platforms
Point of Care Diagnostics - POCD Sample Type Segment Analysis
- Blood Sample
- Nasopharyngeal Swab
- Urine Sample
- Saliva Sample
- Other Sample Types
Point of Care Diagnostics - POCD End Use Segment Analysis
The Point of Care Diagnostics Market Clinics have the highest market share in 2022.
The market is fuelled by Pharmacy and Retail Clinic sector as regulatory agencies are increasing the validation/verification requirements for POC devices because of POCT utilisation rises in hospitals. The primary causes of the expansion of POC diagnostics applications include rising affordability, expanding healthcare coverage, and increasing availability to novel diagnostic technology.
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratory
Author's Detail
Anushka GoreResearch Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses
I played a pivotal role in conducting market research and competitive analysis. I have a demonstrated ability to synthesize diverse data sources, identify trends, and translate findings into actionable recommendations. My collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization. I am committed to maintaining excellence through continuous learning and staying ahead of industry trends. Regular participation in conferences and professional development opportunities keeps my skills sharp and relevant.
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Point of Care Diagnostics - POCD Market is witnessing significant growth in the near future.
In 2023, the Glucose Testing segment accounted for noticeable share of global Point of Care Diagnostics - POCD Market and is projected to experience significant growth in the near future.
The Consumables segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Danaher; Qiagen; Abbott; Siemens Healthcare AG; F. Hoffmann-La Roche Ltd.; bioMerieux SA; Nova Biomedical; Quidel Corp.; Sekisui Diagnostics; Trinity Biotech., and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Frequently Asked Questions (FAQs)
Latest News about Point of Care Diagnostics - POCD Market
Sources from Medical Devices & Consumables Industry
- http://www.trade.gov
- http://www.gov.uk
- http://www.fda.gov
- http://www.hhs.gov
- http://www.who.int
- http://www.bls.gov
- http://www.gao.gov
- http://www.ncbi.nlm.nih.gov
- http://www.healthcaredive.com
- http://www.weforum.org
- http://www.health.gov.za
- http://www.usaid.gov
- http://www.eumdr.com
- http://www.cdc.gov
- http://www.ama-assn.org
- http://www.washingtonpost.com
- http://www.ecfr.gov
- http://www.hbr.org
- http://www.worldbank.org
- http://www.commission.europa.eu
- http://www.cbi.eu
- http://www.unicef.org
- http://www.ecipe.org
- http://www.ema.europa.eu
Point of Care Diagnostics - POCD Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Product | Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease, Infections, Cardiac Markers, Thyroid Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuse (DOA) Testing, Urinalysis/Nephrology |
| Offering | Consumables, Instruments, Software and Services |
| Platform | Lateral Flow Assays, Molecular Diagnostics, Other Platforms |
| Sample Type | Blood Sample, Nasopharyngeal Swab, Urine Sample, Saliva Sample, Other Sample Types |
| End Use | Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory |
| List of Competitors | Danaher; Qiagen; Abbott; Siemens Healthcare AG; F. Hoffmann-La Roche Ltd.; bioMerieux SA; Nova Biomedical; Quidel Corp.; Sekisui Diagnostics; Trinity Biotech. |
This chapter will help you gain GLOBAL Market Analysis of Point of Care Diagnostics - POCD. Further deep in this chapter, you will be able to review Global Point of Care Diagnostics - POCD Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Point of Care Diagnostics - POCD Market Size, Trend Analysis 2019 - 2031
-
1.2 Global Point of Care Diagnostics - POCD Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Point of Care Diagnostics - POCD Revenue Market Size By Region
-
-
1.3 Global Point of Care Diagnostics - POCD Market Size By Product 2019 -2031
-
1.3.1 Glucose Testing Market Size
-
1.3.2 Hb1Ac Testing Market Size
-
1.3.3 Coagulation Testing Market Size
-
1.3.4 Fertility/Pregnancy Market Size
-
1.3.5 Infectious Disease Market Size
-
1.3.6 Infections Market Size
-
1.3.7 Cardiac Markers Market Size
-
1.3.8 Thyroid Stimulating Hormone Market Size
-
1.3.9 Hematology Market Size
-
1.3.10 Primary Care Systems Market Size
-
1.3.11 Decentralized Clinical Chemistry Market Size
-
1.3.12 Feces Market Size
-
1.3.13 Lipid Testing Market Size
-
1.3.14 Cancer Marker Market Size
-
1.3.15 Blood Gas/Electrolytes Market Size
-
1.3.16 Ambulatory Chemistry Market Size
-
1.3.17 Drug of Abuse (DOA) Testing Market Size
-
1.3.18 Urinalysis/Nephrology Market Size
-
-
1.4 Global Point of Care Diagnostics - POCD Market Size By Offering 2019 -2031
-
1.4.1 Consumables Market Size
-
1.4.2 Instruments Market Size
-
1.4.3 Software and Services Market Size
-
-
1.5 Global Point of Care Diagnostics - POCD Market Size By Platform 2019 -2031
-
1.5.1 Lateral Flow Assays Market Size
-
1.5.2 Molecular Diagnostics Market Size
-
1.5.3 Other Platforms Market Size
-
-
1.6 Global Point of Care Diagnostics - POCD Market Size By Sample Type for 2019 -2031
-
1.6.1 Blood Sample Market Size
-
1.6.2 Nasopharyngeal Swab Market Size
-
1.6.3 Urine Sample Market Size
-
1.6.4 Saliva Sample Market Size
-
1.6.5 Other Sample Types Market Size
-
-
1.7 Global Point of Care Diagnostics - POCD Market Size By End Use for 2019 -2031
-
1.7.1 Clinics Market Size
-
1.7.2 Hospitals Market Size
-
1.7.3 Home Market Size
-
1.7.4 Assisted Living Healthcare Facilities Market Size
-
1.7.5 Laboratory Market Size
-
-
1.8 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.9 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.9.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.9.2 Global Market Revenue Split By Product
-
1.9.3 Global Market Revenue Split By Offering
-
1.9.4 Global Market Revenue Split By Platform
-
1.9.5 Global Market Revenue Split By Sample Type
-
1.9.6 Global Market Revenue Split By End Use
-
1.9.7 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
Chapter 2 North America Market Analysis
-
2.1 North America Point of Care Diagnostics - POCD Market Size 2019 - 2031
-
2.1.1 North America Point of Care Diagnostics - POCD Market Size By Country 2019 - 2031
-
2.1.2 North America Point of Care Diagnostics - POCD Market Size by Product 2019 -2031
-
2.1.2.1 North America Glucose Testing Market Size
-
2.1.2.2 North America Hb1Ac Testing Market Size
-
2.1.2.3 North America Coagulation Testing Market Size
-
2.1.2.4 North America Fertility/Pregnancy Market Size
-
2.1.2.5 North America Infectious Disease Market Size
-
2.1.2.6 North America Infections Market Size
-
2.1.2.7 North America Cardiac Markers Market Size
-
2.1.2.8 North America Thyroid Stimulating Hormone Market Size
-
2.1.2.9 North America Hematology Market Size
-
2.1.2.10 North America Primary Care Systems Market Size
-
2.1.2.11 North America Decentralized Clinical Chemistry Market Size
-
2.1.2.12 North America Feces Market Size
-
2.1.2.13 North America Lipid Testing Market Size
-
2.1.2.14 North America Cancer Marker Market Size
-
2.1.2.15 North America Blood Gas/Electrolytes Market Size
-
2.1.2.16 North America Ambulatory Chemistry Market Size
-
2.1.2.17 North America Drug of Abuse (DOA) Testing Market Size
-
2.1.2.18 North America Urinalysis/Nephrology Market Size
-
-
2.1.3 North America Point of Care Diagnostics - POCD Market Size by Offering 2019 -2031
-
2.1.3.1 North America Consumables Market Size
-
2.1.3.2 North America Instruments Market Size
-
2.1.3.3 North America Software and Services Market Size
-
-
2.1.4 North America Point of Care Diagnostics - POCD Market Size by Platform 2019 -2031
-
2.1.4.1 North America Lateral Flow Assays Market Size
-
2.1.4.2 North America Molecular Diagnostics Market Size
-
2.1.4.3 North America Other Platforms Market Size
-
-
2.1.5 North America Point of Care Diagnostics - POCD Market Size by Sample Type 2019 -2031
-
2.1.5.1 North America Blood Sample Market Size
-
2.1.5.2 North America Nasopharyngeal Swab Market Size
-
2.1.5.3 North America Urine Sample Market Size
-
2.1.5.4 North America Saliva Sample Market Size
-
2.1.5.5 North America Other Sample Types Market Size
-
-
2.1.6 North America Point of Care Diagnostics - POCD Market Size by End Use 2019 -2031
-
2.1.6.1 North America Clinics Market Size
-
2.1.6.2 North America Hospitals Market Size
-
2.1.6.3 North America Home Market Size
-
2.1.6.4 North America Assisted Living Healthcare Facilities Market Size
-
2.1.6.5 North America Laboratory Market Size
-
-
-
2.2 Add-Ons: Customize the Report Edition
Purchase Add-Ons to Customize the Report Edition and get further granular data level data about the North America market. Add-On Cost: Request before placing the order, Respective Pricing will be informed after sending the inquiry
-
2.2.1 North America Company Market Share 2019 till 2023
-
2.2.2 Qualitative Analysis for North America Market
Qualitative Analysis for the North America Market: North America Point of Care Diagnostics - POCD Market Trends North America Point of Care Diagnostics - POCD Technological Road Map North America Point of Care Diagnostics - POCD Market Drivers North America Point of Care Diagnostics - POCD Market Restraints North America Point of Care Diagnostics - POCD Market Opportunity Market Attractiveness Analysis COVID – 19 Impact Analysis PESTEL Analysis Porter’s Five Forces Analysis Product Life Cycle Industrial Chain Analysis
-
-
2.3 Executive Summary North America Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary North America Market (2019 vs 2024 vs 2031)
-
2.3.1 North America Market Summary 2019 vs 2024 vs 2031
-
2.3.2 North America Market Revenue Split By Product
-
2.3.3 North America Market Revenue Split By Offering
-
2.3.4 North America Market Revenue Split By Platform
-
2.3.5 North America Market Revenue Split By Sample Type
-
2.3.6 North America Market Revenue Split By End Use
-
Chapter 3 Europe Market Analysis
-
3.1 Europe Point of Care Diagnostics - POCD Market Size 2019 - 2031
-
3.1.1 Europe Point of Care Diagnostics - POCD Market Size By Country 2019 - 2031
-
3.1.2 Europe Point of Care Diagnostics - POCD Market Size by Product 2019 -2031
-
3.1.2.1 Europe Glucose Testing Market Size
-
3.1.2.2 Europe Hb1Ac Testing Market Size
-
3.1.2.3 Europe Coagulation Testing Market Size
-
3.1.2.4 Europe Fertility/Pregnancy Market Size
-
3.1.2.5 Europe Infectious Disease Market Size
-
3.1.2.6 Europe Infections Market Size
-
3.1.2.7 Europe Cardiac Markers Market Size
-
3.1.2.8 Europe Thyroid Stimulating Hormone Market Size
-
3.1.2.9 Europe Hematology Market Size
-
3.1.2.10 Europe Primary Care Systems Market Size
-
3.1.2.11 Europe Decentralized Clinical Chemistry Market Size
-
3.1.2.12 Europe Feces Market Size
-
3.1.2.13 Europe Lipid Testing Market Size
-
3.1.2.14 Europe Cancer Marker Market Size
-
3.1.2.15 Europe Blood Gas/Electrolytes Market Size
-
3.1.2.16 Europe Ambulatory Chemistry Market Size
-
3.1.2.17 Europe Drug of Abuse (DOA) Testing Market Size
-
3.1.2.18 Europe Urinalysis/Nephrology Market Size
-
-
3.1.3 Europe Point of Care Diagnostics - POCD Market Size by Offering 2019 -2031
-
3.1.3.1 Europe Consumables Market Size
-
3.1.3.2 Europe Instruments Market Size
-
3.1.3.3 Europe Software and Services Market Size
-
-
3.1.4 Europe Point of Care Diagnostics - POCD Market Size by Platform 2019 -2031
-
3.1.4.1 Europe Lateral Flow Assays Market Size
-
3.1.4.2 Europe Molecular Diagnostics Market Size
-
3.1.4.3 Europe Other Platforms Market Size
-
-
3.1.5 Europe Point of Care Diagnostics - POCD Market Size by Sample Type 2019 -2031
-
3.1.5.1 Europe Blood Sample Market Size
-
3.1.5.2 Europe Nasopharyngeal Swab Market Size
-
3.1.5.3 Europe Urine Sample Market Size
-
3.1.5.4 Europe Saliva Sample Market Size
-
3.1.5.5 Europe Other Sample Types Market Size
-
-
3.1.6 Europe Point of Care Diagnostics - POCD Market Size by End Use 2019 -2031
-
3.1.6.1 Europe Clinics Market Size
-
3.1.6.2 Europe Hospitals Market Size
-
3.1.6.3 Europe Home Market Size
-
3.1.6.4 Europe Assisted Living Healthcare Facilities Market Size
-
3.1.6.5 Europe Laboratory Market Size
-
-
-
3.2 Add-Ons: Customize the Report Edition
-
3.2.1 Europe Company Market Share 2019 till 2023
-
3.2.2 Qualitative Analysis for Europe Market
-
-
3.3 Executive Summary Europe Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary Europe Market (2019 vs 2024 vs 2031)
-
3.3.1 Europe Revenue Market Summary 2019 vs 2024 vs 2031
-
3.3.2 Europe Market Revenue Split By Product
-
3.3.3 Europe Market Revenue Split By Offering
-
3.3.4 Europe Market Revenue Split By Platform
-
3.3.5 Europe Market Revenue Split By Sample Type
-
3.3.6 Europe Market Revenue Split By End Use
-
Chapter 4 Asia-Pacific Market Analysis
-
4.1 Asia Pacific Point of Care Diagnostics - POCD Market Size 2019 - 2031
-
4.1.1 Asia Pacific Point of Care Diagnostics - POCD Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific Point of Care Diagnostics - POCD Market Size by Product 2019 -2031
-
4.1.2.1 Asia Pacific Glucose Testing Market Size
-
4.1.2.2 Asia Pacific Hb1Ac Testing Market Size
-
4.1.2.3 Asia Pacific Coagulation Testing Market Size
-
4.1.2.4 Asia Pacific Fertility/Pregnancy Market Size
-
4.1.2.5 Asia Pacific Infectious Disease Market Size
-
4.1.2.6 Asia Pacific Infections Market Size
-
4.1.2.7 Asia Pacific Cardiac Markers Market Size
-
4.1.2.8 Asia Pacific Thyroid Stimulating Hormone Market Size
-
4.1.2.9 Asia Pacific Hematology Market Size
-
4.1.2.10 Asia Pacific Primary Care Systems Market Size
-
4.1.2.11 Asia Pacific Decentralized Clinical Chemistry Market Size
-
4.1.2.12 Asia Pacific Feces Market Size
-
4.1.2.13 Asia Pacific Lipid Testing Market Size
-
4.1.2.14 Asia Pacific Cancer Marker Market Size
-
4.1.2.15 Asia Pacific Blood Gas/Electrolytes Market Size
-
4.1.2.16 Asia Pacific Ambulatory Chemistry Market Size
-
4.1.2.17 Asia Pacific Drug of Abuse (DOA) Testing Market Size
-
4.1.2.18 Asia Pacific Urinalysis/Nephrology Market Size
-
-
4.1.3 Asia Pacific Point of Care Diagnostics - POCD Market Size by Offering 2019 -2031
-
4.1.3.1 Asia Pacific Consumables Market Size
-
4.1.3.2 Asia Pacific Instruments Market Size
-
4.1.3.3 Asia Pacific Software and Services Market Size
-
-
4.1.4 Asia Pacific Point of Care Diagnostics - POCD Market Size by Platform 2019 -2031
-
4.1.4.1 Asia Pacific Lateral Flow Assays Market Size
-
4.1.4.2 Asia Pacific Molecular Diagnostics Market Size
-
4.1.4.3 Asia Pacific Other Platforms Market Size
-
-
4.1.5 Asia Pacific Point of Care Diagnostics - POCD Market Size by Sample Type 2019 -2031
-
4.1.5.1 Asia Pacific Blood Sample Market Size
-
4.1.5.2 Asia Pacific Nasopharyngeal Swab Market Size
-
4.1.5.3 Asia Pacific Urine Sample Market Size
-
4.1.5.4 Asia Pacific Saliva Sample Market Size
-
4.1.5.5 Asia Pacific Other Sample Types Market Size
-
-
4.1.6 Asia Pacific Point of Care Diagnostics - POCD Market Size by End Use 2019 -2031
-
4.1.6.1 Asia Pacific Clinics Market Size
-
4.1.6.2 Asia Pacific Hospitals Market Size
-
4.1.6.3 Asia Pacific Home Market Size
-
4.1.6.4 Asia Pacific Assisted Living Healthcare Facilities Market Size
-
4.1.6.5 Asia Pacific Laboratory Market Size
-
-
-
4.2 Add-Ons: Customize the Report Edition
-
4.2.1 Asia Pacific Company Market Share 2019 till 2023
-
4.2.2 Qualitative Analysis for Asia Pacific Market
-
-
4.3 Executive Summary Asia Pacific Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary Asia Pacific Market (2019 vs 2024 vs 2031)
-
4.3.1 Asia Pacific Market Summary 2019 vs 2024 vs 2031
-
4.3.2 Asia Pacific Market Revenue Split By Product
-
4.3.3 Asia Pacific Market Revenue Split By Offering
-
4.3.4 Asia Pacific Market Revenue Split By Platform
-
4.3.5 Asia Pacific Market Revenue Split By Sample Type
-
4.3.6 Asia Pacific Market Revenue Split By End Use
-
Chapter 5 South America Market Analysis
-
5.1 South America Point of Care Diagnostics - POCD Market Size 2019 - 2031
-
5.1.1 South America Point of Care Diagnostics - POCD Revenue Market Size By Country 2019 - 2031
-
5.1.2 South America Point of Care Diagnostics - POCD Market Size by Product 2019 -2031
-
5.1.2.1 South America Glucose Testing Market Size
-
5.1.2.2 South America Hb1Ac Testing Market Size
-
5.1.2.3 South America Coagulation Testing Market Size
-
5.1.2.4 South America Fertility/Pregnancy Market Size
-
5.1.2.5 South America Infectious Disease Market Size
-
5.1.2.6 South America Infections Market Size
-
5.1.2.7 South America Cardiac Markers Market Size
-
5.1.2.8 South America Thyroid Stimulating Hormone Market Size
-
5.1.2.9 South America Hematology Market Size
-
5.1.2.10 South America Primary Care Systems Market Size
-
5.1.2.11 South America Decentralized Clinical Chemistry Market Size
-
5.1.2.12 South America Feces Market Size
-
5.1.2.13 South America Lipid Testing Market Size
-
5.1.2.14 South America Cancer Marker Market Size
-
5.1.2.15 South America Blood Gas/Electrolytes Market Size
-
5.1.2.16 South America Ambulatory Chemistry Market Size
-
5.1.2.17 South America Drug of Abuse (DOA) Testing Market Size
-
5.1.2.18 South America Urinalysis/Nephrology Market Size
-
-
5.1.3 South America Point of Care Diagnostics - POCD Market Size by Offering 2019 -2031
-
5.1.3.1 South America Consumables Market Size
-
5.1.3.2 South America Instruments Market Size
-
5.1.3.3 South America Software and Services Market Size
-
-
5.1.4 South America Point of Care Diagnostics - POCD Market Size by Platform 2019 -2031
-
5.1.4.1 South America Lateral Flow Assays Market Size
-
5.1.4.2 South America Molecular Diagnostics Market Size
-
5.1.4.3 South America Other Platforms Market Size
-
-
5.1.5 South America Point of Care Diagnostics - POCD Market Size by Sample Type 2019 -2031
-
5.1.5.1 South America Blood Sample Market Size
-
5.1.5.2 South America Nasopharyngeal Swab Market Size
-
5.1.5.3 South America Urine Sample Market Size
-
5.1.5.4 South America Saliva Sample Market Size
-
5.1.5.5 South America Other Sample Types Market Size
-
-
5.1.6 South America Point of Care Diagnostics - POCD Market Size by End Use 2019 -2031
-
5.1.6.1 South America Clinics Market Size
-
5.1.6.2 South America Hospitals Market Size
-
5.1.6.3 South America Home Market Size
-
5.1.6.4 South America Assisted Living Healthcare Facilities Market Size
-
5.1.6.5 South America Laboratory Market Size
-
-
-
5.2 Add-Ons: Customize the Report Edition
-
5.2.1 South America Company Market Share 2019 till 2023
-
5.2.2 Qualitative Analysis for South America Market
-
-
5.3 Executive Summary South America Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary South America Market (2019 vs 2024 vs 2031)
-
5.3.1 South America Market Summary 2019 vs 2024 vs 2031
-
5.3.2 South America Market Revenue Split By Product
-
5.3.3 South America Market Revenue Split By Offering
-
5.3.4 South America Market Revenue Split By Platform
-
5.3.5 South America Market Revenue Split By Sample Type
-
5.3.6 South America Market Revenue Split By End Use
-
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa Point of Care Diagnostics - POCD Market Size 2019 - 2031
-
6.1.1 Middle East and Africa Point of Care Diagnostics - POCD Revenue Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa Point of Care Diagnostics - POCD Market Size by Product 2019 -2031
-
6.1.2.1 Middle East and Africa Glucose Testing Market Size
-
6.1.2.2 Middle East and Africa Hb1Ac Testing Market Size
-
6.1.2.3 Middle East and Africa Coagulation Testing Market Size
-
6.1.2.4 Middle East and Africa Fertility/Pregnancy Market Size
-
6.1.2.5 Middle East and Africa Infectious Disease Market Size
-
6.1.2.6 Middle East and Africa Infections Market Size
-
6.1.2.7 Middle East and Africa Cardiac Markers Market Size
-
6.1.2.8 Middle East and Africa Thyroid Stimulating Hormone Market Size
-
6.1.2.9 Middle East and Africa Hematology Market Size
-
6.1.2.10 Middle East and Africa Primary Care Systems Market Size
-
6.1.2.11 Middle East and Africa Decentralized Clinical Chemistry Market Size
-
6.1.2.12 Middle East and Africa Feces Market Size
-
6.1.2.13 Middle East and Africa Lipid Testing Market Size
-
6.1.2.14 Middle East and Africa Cancer Marker Market Size
-
6.1.2.15 Middle East and Africa Blood Gas/Electrolytes Market Size
-
6.1.2.16 Middle East and Africa Ambulatory Chemistry Market Size
-
6.1.2.17 Middle East and Africa Drug of Abuse (DOA) Testing Market Size
-
6.1.2.18 Middle East and Africa Urinalysis/Nephrology Market Size
-
-
6.1.3 Middle East and Africa Point of Care Diagnostics - POCD Market Size by Offering 2019 -2031
-
6.1.3.1 Middle East and Africa Consumables Market Size
-
6.1.3.2 Middle East and Africa Instruments Market Size
-
6.1.3.3 Middle East and Africa Software and Services Market Size
-
-
6.1.4 Middle East and Africa Point of Care Diagnostics - POCD Market Size by Platform 2019 -2031
-
6.1.4.1 Middle East and Africa Lateral Flow Assays Market Size
-
6.1.4.2 Middle East and Africa Molecular Diagnostics Market Size
-
6.1.4.3 Middle East and Africa Other Platforms Market Size
-
-
6.1.5 Middle East and Africa Point of Care Diagnostics - POCD Market Size by Sample Type 2019 -2031
-
6.1.5.1 Middle East and Africa Blood Sample Market Size
-
6.1.5.2 Middle East and Africa Nasopharyngeal Swab Market Size
-
6.1.5.3 Middle East and Africa Urine Sample Market Size
-
6.1.5.4 Middle East and Africa Saliva Sample Market Size
-
6.1.5.5 Middle East and Africa Other Sample Types Market Size
-
-
6.1.6 Middle East and Africa Point of Care Diagnostics - POCD Market Size by End Use 2019 -2031
-
6.1.6.1 Middle East and Africa Clinics Market Size
-
6.1.6.2 Middle East and Africa Hospitals Market Size
-
6.1.6.3 Middle East and Africa Home Market Size
-
6.1.6.4 Middle East and Africa Assisted Living Healthcare Facilities Market Size
-
6.1.6.5 Middle East and Africa Laboratory Market Size
-
-
-
6.2 Add-Ons: Customize the Report Edition
-
6.2.1 Middle East and Africa Company Market Share 2019 till 2023
-
6.2.2 Qualitative Analysis for Middle East and Africa Market
-
-
6.3 Executive Summary Middle East and Africa Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary Middle East and Africa Market (2019 vs 2024 vs 2031)
-
6.3.1 Middle East and Africa Market Summary 2019 vs 2024 vs 2031
-
6.3.2 Middle East and Africa Market Revenue Split By Product
-
6.3.3 Middle East and Africa Market Revenue Split By Offering
-
6.3.4 Middle East and Africa Market Revenue Split By Platform
-
6.3.5 Middle East and Africa Market Revenue Split By Sample Type
-
6.3.6 Middle East and Africa Market Revenue Split By End Use
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1Point of Care Diagnostics - POCD Market Size by Product 2019 -2031
-
7.1.2 Country 1Point of Care Diagnostics - POCD Market Size by Offering 2019 -2031
-
7.1.3 Country 1Point of Care Diagnostics - POCD Market Size by Platform 2019 -2031
-
7.1.4 Country 1Point of Care Diagnostics - POCD Market Size by Sample Type 2019 -2031
-
7.1.5 Country 1Point of Care Diagnostics - POCD Market Size by End Use 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global Point of Care Diagnostics - POCD Market Revenue and Share by Manufacturers (2019-2023)
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 Danaher; Qiagen; Abbott; Siemens Healthcare AG; F. Hoffmann-La Roche Ltd.; bioMerieux SA; Nova Biomedical; Quidel Corp.; Sekisui Diagnostics; Trinity Biotech.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Trends
-
9.3 Market Restraints
-
9.4 Market Opportunity
-
9.5 Product Life Cycle (Subject to Data Availability)
-
9.6 Industrial Chain Analysis (Subject to Data Availability)
-
9.6.1 Industry Chain Analysis
-
9.6.2 Manufacturing Cost Analysis
-
9.6.3 Consumer Preference Analysis
-
9.6.4 Supply Side Analysis
-
9.6.4.1 Raw Material Analysis
-
9.6.4.2 Raw Material Procurement Analysis
-
9.6.4.3 Raw Material Price Trend Analysis
-
-
-
9.7 Market Attractiveness Analysis
-
9.8 PESTEL Analysis
-
9.9 Porter’s Five Forces Analysis
-
9.10 Patent Analysis (Subject to Data Availability)
-
9.11 ESG Analysis
-
9.12 Technological Road Map
Segmentation Product Analysis 2019 -2031, will provide market size split by Product. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Product Analysis 2019 -2031
-
10.1 Glucose Testing
-
10.1.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Glucose Testing 2019 -2031
-
-
10.2 Hb1Ac Testing
-
10.2.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Hb1Ac Testing 2019 -2031
-
-
10.3 Coagulation Testing
-
10.3.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Coagulation Testing 2019 -2031
-
-
10.4 Fertility/Pregnancy
-
10.4.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Fertility/Pregnancy 2019 -2031
-
-
10.5 Infectious Disease
-
10.5.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Infectious Disease 2019 -2031
-
-
10.6 Infections
-
10.6.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Infections 2019 -2031
-
-
10.7 Cardiac Markers
-
10.7.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Cardiac Markers 2019 -2031
-
-
10.8 Thyroid Stimulating Hormone
-
10.8.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Thyroid Stimulating Hormone 2019 -2031
-
-
10.9 Hematology
-
10.9.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Hematology 2019 -2031
-
-
10.10 Primary Care Systems
-
10.10.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Primary Care Systems 2019 -2031
-
-
10.11 Decentralized Clinical Chemistry
-
10.11.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Decentralized Clinical Chemistry 2019 -2031
-
-
10.12 Feces
-
10.12.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Feces 2019 -2031
-
-
10.13 Lipid Testing
-
10.13.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Lipid Testing 2019 -2031
-
-
10.14 Cancer Marker
-
10.14.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Cancer Marker 2019 -2031
-
-
10.15 Blood Gas/Electrolytes
-
10.15.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Blood Gas/Electrolytes 2019 -2031
-
-
10.16 Ambulatory Chemistry
-
10.16.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Ambulatory Chemistry 2019 -2031
-
-
10.17 Drug of Abuse (DOA) Testing
-
10.17.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Drug of Abuse (DOA) Testing 2019 -2031
-
-
10.18 Urinalysis/Nephrology
-
10.18.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Urinalysis/Nephrology 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Offering Analysis 2019 -2031
-
11.1 Consumables
-
11.1.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Consumables 2019 - 2031
-
-
11.2 Instruments
-
11.2.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Instruments 2019 - 2031
-
-
11.3 Software and Services
-
11.3.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Software and Services 2019 - 2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Platform Analysis 2019 -2031
-
12.1 Lateral Flow Assays
-
12.1.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Lateral Flow Assays 2019 -2031
-
-
12.2 Molecular Diagnostics
-
12.2.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Molecular Diagnostics 2019 -2031
-
-
12.3 Other Platforms
-
12.3.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Other Platforms 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Sample Type Analysis 2019 -2031
-
13.1 Blood Sample
-
13.1.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Blood Sample 2019 -2031
-
-
13.2 Nasopharyngeal Swab
-
13.2.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Nasopharyngeal Swab 2019 -2031
-
-
13.3 Urine Sample
-
13.3.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Urine Sample 2019 -2031
-
-
13.4 Saliva Sample
-
13.4.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Saliva Sample 2019 -2031
-
-
13.5 Other Sample Types
-
13.5.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Other Sample Types 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 14 Market Split by End Use Analysis 2019 -2031
-
14.1 Clinics
-
14.1.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Clinics 2019 -2031
-
-
14.2 Hospitals
-
14.2.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Hospitals 2019 -2031
-
-
14.3 Home
-
14.3.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Home 2019 -2031
-
-
14.4 Assisted Living Healthcare Facilities
-
14.4.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Assisted Living Healthcare Facilities 2019 -2031
-
-
14.5 Laboratory
-
14.5.1 Global Point of Care Diagnostics - POCD Revenue Market Size and Share by Laboratory 2019 -2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Point of Care Diagnostics - POCD market
Chapter 15 Research Findings
-
15.1 Key Takeaways
-
15.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
15.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Anushka Gore and Team
- 1.1 Point of Care Diagnostics - POCD Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for Point of Care Diagnostics - POCD Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for Point of Care Diagnostics - POCD Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for Point of Care Diagnostics - POCD Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for Point of Care Diagnostics - POCD Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for Point of Care Diagnostics - POCD Market
Key Questions Answered By Point of Care Diagnostics - POCD Market Report 2024
| Why Glucose Testing have a significant impact on Point of Care Diagnostics - POCD market? |
| What are the key factors affecting the Glucose Testing and Hb1Ac Testing of Point of Care Diagnostics - POCD Market? |
| What is the CAGR/Growth Rate of Consumables during the forecast period? |
| By type, which segment accounted for largest share of the global Point of Care Diagnostics - POCD Market? |
| Which region is expected to dominate the global Point of Care Diagnostics - POCD Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
